LLY vs XOM: Eli Lilly and and Exxon Mobil compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- Eli Lilly and is the larger company, worth $1.08T, about 1.5 times Exxon Mobil.
- Eli Lilly and grew revenue faster over the last year (+47.7% vs +42.3%).
- On earnings, Exxon Mobil is the cheaper stock (29.1x vs 43.0x).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | LLY | XOM |
|---|---|---|
| Market cap | $1.08T | $717.4B |
| Share price | $1,179.27 | $168.94 |
| Revenue (last fiscal year) | $65.2B | $332.2B |
| Free cash flow (last fiscal year) | — | $23.6B |
| Revenue growth, last year | +47.7% | +42.3% |
| Revenue growth per year, last 5 fiscal years | +23.2% | +4.7% |
| Operating margin | — | 12.3% |
| Net margin | 33.5% | 8.9% |
| Return on equity | 78.8% | 12.6% |
| P/E (trailing) | 43.0x | 29.1x |
| Price / free cash flow | 120.2x | 30.4x |
| EV / EBITDA | 30.4x | 10.0x |
| FCF growth the price implies | — | 10.5% |
| Dividend yield | 0.53% | 2.3% |
| Debt / equity | 3.20x | 0.76x |
| Fundamental grade | C | C |
| Superinvestors holding it | 12 | 13 |
| Insider purchases, last 12 months | 10 | 10 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
Eli Lilly and
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $28.3B | — | — |
| 2022 | $28.5B | — | — |
| 2023 | $34.1B | — | — |
| 2024 | $45.0B | — | — |
| 2025 | $65.2B | — | — |
Exxon Mobil
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $276.7B | $36.1B | 8.1% |
| 2022 | $413.7B | $58.4B | 18.8% |
| 2023 | $344.6B | $33.5B | 15.3% |
| 2024 | $349.6B | $30.7B | 14.0% |
| 2025 | $332.2B | $23.6B | 12.4% |
Where the revenue comes from
Eli Lilly and · by products, 2025
Net product revenue$61.0B94%
Collaboration and Other Revenue$4.2B6%
Exxon Mobil
No segment breakdown reported.
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open LLY in InvestinglyQuestions
Which is bigger, Eli Lilly and or Exxon Mobil?
Eli Lilly and (LLY), at $1.08T against $717.4B.
Is LLY or XOM cheaper?
By trailing P/E, Exxon Mobil (29.1x) is cheaper than Eli Lilly and (43.0x). A lower multiple can also mean the market expects less growth.
Which grows faster, LLY or XOM?
Eli Lilly and: revenue grew +47.7% over the last year, against +42.3%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.